BENDAMUSTINE IN HEAVILY TREATED HODGKIN LYMPHOMA, A RETROSPECTIVE FRENCH STUDY IN 28 PATIENTS

被引：0
|
作者：
Brice, P. [1 ]
Ghesquieres, H. [2 ]
Stamatoullas, A. [3 ]
Casanovas, O. [4 ]
Morschhauser, F. [5 ]
Gyan, E. [6 ]
Gabarre, J. [7 ]
Malphettes, M. [1 ]
Clement, L. [8 ]
机构：
[1] Hop St Louis, Paris, France
[2] Ctr Leon Berard, Lyon, France
[3] Ctr Henri Becquerel, Rouen, France
[4] CHU Bocage, Dijon, France
[5] CHU Lille, Lille, France
[6] CHU Bretonneau, Tours, France
[7] Hop Pitie, Paris, France
[8] CHU Brabois, Nancy, France
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0214
引用
收藏
页码：86 / 86
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of bendamustine for the treatment of patients with recurring Hodgkin lymphoma
    Corazzelli, Gaetano
    Angrilli, Francesco
    D'Arco, Alfonso
    Ferrara, Felicetto
    Musto, Pellegrino
    Guarini, Attilio
    Cox, Maria Christina
    Stelitano, Caterina
    Storti, Sergio
    Iannitto, Emilio
    Falorio, Simona
    Califano, Catello
    Amore, Alfonso
    Arcamone, Manuela
    De Filippi, Rosaria
    Pinto, Antonio
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 160 (02) : 207 - 215
  • [22] Brentuximab vedotin in heavily treated Hodgkin and anaplastic large-cell lymphoma, a single centre study on 45 patients
    Monjanel, Helene
    Deville, Laure
    Ram-Wolff, Caroline
    Venon, Marie-Dominique
    Franchi, Patricia
    Benet, Claire
    de Kerviler, Eric
    Malphettes, Marion
    Thieblemont, Catherine
    Brice, Pauline
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 166 (02) : 306 - +
  • [23] Phase II Study of Bendamustine in Relapsed and Refractory Hodgkin Lymphoma
    Moskowitz, Alison J.
    Hamlin, Paul A., Jr.
    Perales, Miguel-Angel
    Gerecitano, John
    Horwitz, Steven M.
    Matasar, Matthew J.
    Noy, Ariela
    Palomba, Maria Lia
    Portlock, Carol S.
    Straus, David J.
    Graustein, Tricia
    Zelenetz, Andrew D.
    Moskowitz, Craig H.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04) : 456 - 460
  • [24] Bendamustine Monotherapy Is Effective As Salvage Therapy in Patients with Refractory / Relapsed Pediatric Hodgkin Lymphoma (HL): A Retrospective Analysis
    Tandon, Sneha
    Banavali, Shripad
    Arora, Brijesh
    Narula, Gaurav
    Prasad, Maya
    Shet, Tanuja
    Gujral, Sumeet
    BLOOD, 2015, 126 (23)
  • [25] The efficacy of lenalidomide combination therapy in heavily pretreated non-Hodgkin lymphoma patients: an Italian observational, multicenter, retrospective study
    Zinzani, Pier Luigi
    Rigacci, Luigi
    Cox, Maria Cristina
    Devizzi, Liliana
    Fabbri, Alberto
    Zaja, Francesco
    Di Rocco, Alice
    Rossi, Giuseppe
    Storti, Sergio
    Fattori, Pier Paolo
    Argnani, Lisa
    Vitolo, Umberto
    LEUKEMIA & LYMPHOMA, 2017, 58 (01) : 226 - 229
  • [26] Bendamustine efficacy in Hodgkin lymphoma patients relapsed/refractory to brentuximab vedotin
    Zinzani, Pier Luigi
    Derenzini, Enrico
    Pellegrini, Cinzia
    Celli, Monica
    Broccoli, Alessandro
    Argnani, Lisa
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 163 (05) : 681 - 683
  • [27] Minimal residual disease analysis in patients with follicular lymphoma treated with obinutuzumab plus bendamustine versus bendamustine alone in GADOLIN, a phase III study of relapsed/refractory indolent non-Hodgkin lymphoma
    Pott, C.
    Belada, D.
    Danesi, N.
    Fingerle-Rowson, G.
    Gribben, J.
    Harbron, C.
    Hoster, E.
    Kahl, B.
    Mundt, K.
    Sebban, C.
    Sehn, L. H.
    Cheson, B. D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 : 93 - 94
  • [28] Bendamustine in combination with ifosfamide, etoposide, and vinorelbine (VIBE) is an effective salvage regimen for heavily pre-treated patients with relapsed or refractory Hodgkin lymphoma: a single-center experience
    Prakash, Gaurav
    Jain, Arihant
    Sahu, Kamalkant
    Bal, Amanjit
    Singh, Charanpreet
    Basher, Rajender
    Singh, Harmandeep
    Mishra, Kundan
    Jandial, Aditya
    Lad, Deepesh
    Khadwal, Alka
    Srinivasan, Radhika
    Das, Ashim
    Varma, Neelam
    Varma, Subhash
    Malhotra, Pankaj
    BLOOD RESEARCH, 2021, 56 (03) : 134 - 140
  • [29] SAFETY AND EFFICACY OF BENDAMUSTINE WITH OR WITHOUT RITUXIMAB IN THE TREATMENT OF HEAVILY PRETREATED PATIENTS. A MULTICENTER RETROSPECTIVE STUDY
    Rigacci, L.
    Cortelazzo, S.
    Storti, S.
    Carpaneto, A.
    Di Renzo, N.
    Zinzani, P. L.
    Puccini, B.
    Toldo, C.
    Giordano, G.
    Montanaro, M.
    Pugliese, G.
    Derenzini, E.
    Billio, A.
    Piano, S.
    Bosi, A.
    HAEMATOLOGICA, 2008, 93 : S101 - S101
  • [30] A Phase I Study of Gemcitabine and Bendamustine in Relapsed/Refractory Hodgkin Lymphoma
    Cohen, Jonathon B.
    Wei, Lai
    Maddocks, Kami J.
    Heffner, Leonard T.
    Langston, Amelia
    Flowers, Christopher
    Devine, Steven M.
    Blum, Kristie A.
    BLOOD, 2015, 126 (23)
12345